Rogers, J., Bloch, R., Eudy, A., Pisetsky, D., Alexander, R., Conklin, J., … Clowse, M. (2021). Cell-bound Complement Activation Products (CB-CAPs) Predicts Type 1 SLE Activity. In ARTHRITIS & RHEUMATOLOGY (Vol. 73, pp. 1800–1802).

Rogers, Jennifer, Rory Bloch, Amanda Eudy, David Pisetsky, Roberta Alexander, John Conklin, Kai Sun, et al. “Cell-bound Complement Activation Products (CB-CAPs) Predicts Type 1 SLE Activity.” In ARTHRITIS & RHEUMATOLOGY, 73:1800–1802, 2021.

Rogers J, Bloch R, Eudy A, Pisetsky D, Alexander R, Conklin J, et al. Cell-bound Complement Activation Products (CB-CAPs) Predicts Type 1 SLE Activity. In: ARTHRITIS & RHEUMATOLOGY. 2021. p. 1800–2.

Rogers, Jennifer, et al. “Cell-bound Complement Activation Products (CB-CAPs) Predicts Type 1 SLE Activity.” ARTHRITIS & RHEUMATOLOGY, vol. 73, 2021, pp. 1800–02.

Rogers J, Bloch R, Eudy A, Pisetsky D, Alexander R, Conklin J, Sun K, Sadun R, Criscione-Schreiber L, Doss J, Clowse M. Cell-bound Complement Activation Products (CB-CAPs) Predicts Type 1 SLE Activity. ARTHRITIS & RHEUMATOLOGY. 2021. p. 1800–1802.